Events Partner Content PREDiCT: Autoimmune Disease Modeling Summit Deploy Advanced Models to Enhance Your Confidence & Und
News Could phase 3 trial win save AZ's troubled Lupus drug? AstraZeneca has been on a hot streak of trial successes recently, with the latest win being in a late-stage study for a potential lupus drug that looked dead and buried after a major trial
News Roche's Gazyva shows promise in Lupus nephritis trial Roche’s Gazyva is already approved in leukaemia and lymphoma – but could it work in the autoimmune kidney disease Lupus nephritis too?
News FDA approves first treatment for children with lupus The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
